EGFR and non-small cell lung carcinoma: The most frequent mutations of the EGFR gene in NSCLC patients are located in four tyrosine kinase domain coding exons (in the ATP-binding region)—exons 18, 19, 20 and 21 (Figure 1), which are considered as activators since they result in an increase of the receptor kinase activity [11,12].